Gene · 7704
Papers3,197
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,197
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring molecular mechanisms underlying the pathophysiological association between knee osteoarthritis and sarcopenia. | Osteoporos Sarcopenia | 2023 | 37941536 | PubTator, text mining | PubMed |
| The m6A/m1A/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome. | J Inflamm Res | 2023 | 37933335 | PubTator, text mining | PubMed |
| Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1. | Sci Rep | 2023 | 37923825 | PubTator, text mining | PubMed |
| Both Horatio and Polonius: Innate Lymphoid Cells in Tissue Homeostasis and Repair. | Immunohorizons | 2023 | 37916861 | PubTator, text mining | PubMed |
| Innate lymphoid cells: a new key player in atopic dermatitis. | Front Immunol | 2023 | 37908364 | PubTator, text mining | PubMed |
| Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity. | EMBO Mol Med | 2023 | 37902007 | PubTator, text mining | PubMed |
| Transcription and chromatin regulation by TAF4b during cellular quiescence of developing prospermatogonia. | Front Cell Dev Biol | 2023 | 37900284 | PubTator, text mining | PubMed |
| BRD9-mediated control of the TGF-β/Activin/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells. | Nucleic Acids Res | 2023 | 37870468 | PubTator, text mining | PubMed |
| Prognostic risk of immune-associated signature in the microenvironment of brain gliomas. | Front Genet | 2023 | 37867596 | PubTator, text mining | PubMed |
| Homeostatic cytokines reciprocally modulate the emergence of prenatal effector PLZF+CD4+ T cells in humans. | JCI Insight | 2023 | 37856221 | PubTator, text mining | PubMed |
| Circular RNA-FK501 binding protein 51 boosts bone marrow mesenchymal stem cell proliferation and osteogenic differentiation via modulating microRNA-205-5p/Runt-associated transcription factor 2 axis. | J Orthop Surg Res | 2023 | 37853466 | PubTator, text mining | PubMed |
| Modelling in vitro gametogenesis using induced pluripotent stem cells: a review. | Cell Regen | 2023 | 37843621 | PubTator, text mining | PubMed |
| Derivation of Arbas Cashmere Goat Induced Pluripotent Stem Cells in LCDM with Trophectoderm Lineage Differentiation and Interspecies Chimeric Abilities. | Int J Mol Sci | 2023 | 37834175 | PubTator, text mining | PubMed |
| SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo. | J Virol | 2023 | 37830818 | PubTator, text mining | PubMed |
| Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions. | J Transl Med | 2023 | 37828515 | PubTator, text mining | PubMed |
| Production of Highly Uniform Midbrain Organoids from Human Pluripotent Stem Cells. | Stem Cells Int | 2023 | 37810631 | PubTator, text mining | PubMed |
| Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses. | Front Immunol | 2023 | 37809084 | PubTator, text mining | PubMed |
| Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer. | Cancer Cell Int | 2023 | 37803446 | PubTator, text mining | PubMed |
| Insight into microRNAs' involvement in hematopoiesis: current standing point of findings. | Stem Cell Res Ther | 2023 | 37794439 | PubTator, text mining | PubMed |
| Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma. | Clin Transl Med | 2023 | 37784253 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7704/papers?page=11